🔎 Trials Near Me

Akèy › Adenokasinom Ezofajyen › Michigan › Ann Arbor

Etid klinik pou Adenokasinom Ezofajyen nan Ann Arbor, MI

7 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Ap rekriteFaz 2/3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • Chelsea Hospital, Chelsea · 15 mi lwen
  • ak 3 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Ap rekriteFaz 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • ak 4 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Ap rekriteFaz 2
  • University of Michigan Rogel Cancer Center, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06732388

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Ap rekrite
  • University of Michigan, Ann Arbor
Laj 18 a 89 · Tout sèks · Mizajou Sep 11, 2026 · NCT05753748

Obeticholic Acid for Prevention in Barrett's Esophagus

Ap rekriteFaz 2
  • University of Michigan Rogel Cancer Center, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT04939051

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Ap rekriteFaz 2
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Nov 5, 2025 · NCT05563766

Etid Adenokasinom Ezofajyen nan lòt vil

Lòt etid nan Ann Arbor

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.